$0.00
(0.00%)
| Today's Open | $10.13 |
|---|---|
| Previous Close | $10.14 |
| Daily Range | $9.94 - $10.21 |
| 52-Week Range | $7.21 - $12.77 |
| Market Cap | $816.8M |
| P/E Ratio | -3.69 |
| Dividend (Yield) | $0.00 (0.0%) |
| Volume | 975,976 |
| Average Daily Volume | 1,481,804 |
| Current FY EPS | -$2.75 |
Sector
Healthcare
Industry
Drugs
InterMune (ITMN) Description
The Company is a biotech company focused on developing and commercializing innovative therapies in pulmonology and hepatology. Website: http://www.intermune.com/
News & Commentary
A look back at the biggest stories this week in biotech and what they mean for investors.
Is this meaningful? Or just another movement?
National Institute for Health and Clinical Excellence in England and Wales Recommends Esbriet for Mi
National Institute for Health and Clinical Excellence in England and Wales Recommends Esbriet for Mild to Moderate IPFITMN's Top Competitors
(-1.38%)
(2.02%)
(1.31%)
(2.73%)